APA (7th ed.) Citation

Hankey, G., & Hacke, W. (2014). Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: The rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke, 45(5), . https://doi.org/10.1161/STROKEAHA.113.004506

Chicago Style (17th ed.) Citation

Hankey, Graeme, and Werner Hacke. "Intracranial Hemorrhage Among Patients with Atrial Fibrillation Anticoagulated with Warfarin or Rivaroxaban: The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation." Stroke 45, no. 5 (2014). https://doi.org/10.1161/STROKEAHA.113.004506.

MLA (9th ed.) Citation

Hankey, Graeme, and Werner Hacke. "Intracranial Hemorrhage Among Patients with Atrial Fibrillation Anticoagulated with Warfarin or Rivaroxaban: The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation." Stroke, vol. 45, no. 5, 2014, https://doi.org/10.1161/STROKEAHA.113.004506.